Survivorship in Lynch Syndrome Families
Cancer Survivorship in Lynch Syndrome: Impact on Patients and Families
2 other identifiers
observational
303
1 country
1
Brief Summary
Objectives: Specific Aims:
- 1.Researchers will evaluate and compare predictors of health-related quality of life (QOL) among colorectal cancer (CRC) survivors who have Lynch syndrome (LS) with those patients who have sporadic CRC using both quantitative and qualitative methodology.
- 2.Researchers will compare the experience of first-degree relatives (FDRs) of patients who have LS with that of FDRs of patients who have sporadic CRC using both quantitative and qualitative methodology.
- 3.Researchers will examine CRC patients from both groups and their FDRs using dyadic analyses in order to evaluate the similarities and differences in their survivorship experience.
- 4.Researchers will evaluate the preventive and health behavior of patients who are non-conclusive for Lynch syndrome and their family members. They will examine their screening behavior and will explore how the interaction between the patients and their relatives affects the relatives' screening behavior. They also will examine how these non conclusive LS patients and their family members perceive their risk for LS-related cancers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2010
CompletedFirst Posted
Study publicly available on registry
May 20, 2010
CompletedStudy Start
First participant enrolled
June 20, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 19, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 19, 2022
CompletedOctober 20, 2022
October 1, 2022
12.3 years
May 18, 2010
October 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Compare Predictors of Health-Related Quality of Life (QOL) among Colorectal Cancer (CRC) Survivors who have Lynch Syndrome (LS) with patients who have Sporadic CRC
1 Year
Study Arms (1)
Questionnaire + Telephone Interview
Mailed questionnaire that contains questions about experiences living with colorectal cancer, take 45-60 minutes to complete. The phone interview should take 30-45 minutes to complete.
Interventions
The phone interview should take 30-45 minutes to complete.
Mailed questionnaire that contains questions about experiences living with colorectal cancer, take 45-60 minutes to complete.
Eligibility Criteria
Colorectal cancer (CRC) patients with Lynch-syndrome related CRC or with sporadic CRC; along with first-degree relatives (FDRs), Siblings or adult children of recruited CRC patients
You may qualify if:
- Colorectal cancer (CRC) patients with Lynch-syndrome related CRC: Diagnosis of CRC
- Colorectal cancer (CRC) patients with sporadic CRC: Diagnosis of CRC
- All First-degree relatives (FDRs): Siblings or adult children of recruited CRC patients
- All Participants: 18 years of age or older
- All Participants: Able to read and speak English
- All Participants: Able to be contacted by mail.
- All Second and Third relatives (SDRs and TDRs): Grandparents, grandchildren, aunts, uncles, nieces, nephews, and first-degree cousins of recruited CRC patients
- IPs with a LS MMR mutation who were seen at MDACC for genetic counseling and testing during 2011-2014.
You may not qualify if:
- \) CRC patients with sporadic CRC: Personal or family history of Lynch syndrome, familial adenomatous polyposis, inflammatory bowel disease or those who have a FDR with CRC
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- M.D. Anderson Cancer Centerlead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Susan Peterson, MPH,PHD
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 18, 2010
First Posted
May 20, 2010
Study Start
June 20, 2010
Primary Completion
September 19, 2022
Study Completion
September 19, 2022
Last Updated
October 20, 2022
Record last verified: 2022-10